Extracellular matrix components prevent lipopolysaccharide-induced bovine arterial endothelial cell injury by inhibiting p38 mitogen-activated protein kinase.

Abstract:

:The effect of extracellular matrix components on lipopolysaccharide-induced vascular endothelial cell injury was studied by using lipopolysaccharide-susceptible bovine aortic endothelial cells. For evaluation of lipopolysaccharide-induced injury, we estimated DNA synthesis and cell detachment of bovine aortic endothelial cells in cultures using extracellular matrix components-coated plastic dishes. Among extracellular matrix components, matrigel almost completely inhibited the reduction in DNA synthesis and the enhancement in cell detachment of bovine aortic endothelial cells in cultures with lipopolysaccharide. The lipopolysaccharide-induced injury was also inhibited by coating with type IV collagen, gelatin, fibronectin, laminin, vitronectin, and heparin sulphate proteoglycan. Extracellular matrix components capable of preventing lipopolysaccharide-induced bovine aortic endothelial cells injury coincidentally inhibited the phosphorylation of p38 mitogen-activated protein kinase in lipopolysaccharide-treated bovine aortic endothelial cells. SB203580, a specific inhibitor of p38 mitogen-activated protein kinase, also prevented the reduction in DNA synthesis and the enhancement in cell detachment of bovine aortic endothelial cells in cultures with lipopolysaccharide. It was therefore suggested that extracellular matrix components might protect bovine aortic endothelial cells from lipopolysaccharide-induced injury through inhibiting the activation of p38 mitogen-activated protein kinase.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Chakravortty D,Kato Y,Koide N,Sugiyama T,Kawai M,Fukada M,Yoshida T,Yokochi T

doi

10.1016/s0049-3848(99)00226-1

subject

Has Abstract

pub_date

2000-04-15 00:00:00

pages

187-93

issue

2

eissn

0049-3848

issn

1879-2472

pii

S0049-3848(99)00226-1

journal_volume

98

pub_type

杂志文章
  • Genetic prothrombotic risk factors in women with unexplained pregnancy loss.

    abstract:INTRODUCTION:Inherited thrombophilia has been associated with unexplained recurrent pregnancy loss (RPL) and stillbirth. This thrombotic tendency can manifest as thrombotic lesions in the placenta, and may lead to abortion and stillbirth. The aim of our case-control study was to investigate the prevalence of FVL and FI...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2005.06.005

    authors: Sottilotta G,Oriana V,Latella C,Luise F,Piromalli A,Ramirez F,Mammì C,Santoro R,Iannaccaro P,Muleo G,Lombardo VT

    更新日期:2006-01-01 00:00:00

  • Fresh frozen plasma in the pediatric age group and in congenital coagulation factor deficiency.

    abstract::Generally, the rules of good practice in transfusion medicine apply also to the pediatric age group. However, the frequency of specific diseases that might necessitate the administration of fresh frozen plasma (FFP) differs from that in adults. Physiologic differences to the later age exist in the neonatal period and ...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/s0049-3848(02)00149-4

    authors: Muntean W

    更新日期:2002-10-31 00:00:00

  • Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry.

    abstract:BACKGROUND:Bypassing agents are the first line therapy in patients with acquired haemophilia A (AHA). Activated prothrombin complex concentrate (aPCC) proved to be effective as initial treatment, but 20% of patients (pts) had relapses. aPCC as short-term prophylaxis to reduce subsequent bleeds is still not clear. AIM:...

    journal_title:Thrombosis research

    pub_type: 信件

    doi:10.1016/j.thromres.2018.12.006

    authors: Zanon E,Pasca S,Siragusa S,Napolitano M,Santoro C,Mameli L,Rocino A,FAIR Study Group.

    更新日期:2019-02-01 00:00:00

  • Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry.

    abstract:INTRODUCTION:In the treatment of bleeds in haemophilia patients with inhibitors, a high initial dose of recombinant Factor VIIa (rFVIIa) provides at least equal efficacy and a similar safety profile to a standard initial dose. However, no pharmacoeconomic comparison between these dosing regimens has previously been per...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.11.002

    authors: Salaj P,Kubes R,Cetkovsky P,Capova I,Penka M,Ovesná P,Mesterton J,Lindgren P

    更新日期:2014-02-01 00:00:00

  • Bispecific antibody mimicking factor VIII.

    abstract::There are some issues in the current factor (F)VIII replacement therapy for severe hemophilia A. One is mental and physical burden for the multiple intravenous infusions, and the other is difficulty in the hemostatic treatment for the patients with FVIII inhibitor. The development of novel drug with fully hemostatic e...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/S0049-3848(16)30361-9

    authors: Nogami K

    更新日期:2016-05-01 00:00:00

  • A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups.

    abstract:INTRODUCTION:D-dimer, a fibrin degradation product, is related to risk of cardiovascular disease and venous thromboembolism. Genetic determinants of D-dimer are not well characterized; notably, few data have been reported for African American (AA), Asian, and Hispanic populations. MATERIALS AND METHODS:We conducted a ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.05.018

    authors: Weng LC,Tang W,Rich SS,Smith NL,Redline S,O'Donnell CJ,Basu S,Reiner AP,Delaney JA,Tracy RP,Palmer CD,Young T,Yang Q,Folsom AR,Cushman M

    更新日期:2014-08-01 00:00:00

  • The effects of recombinant activated factor VII dose on the incidence of thromboembolic events in patients with coagulopathic bleeding.

    abstract:INTRODUCTION:Previous studies have suggested the used of off-label recombinant factor VII (rFVIIa) increases the risk of thromboembolic events, but the effect of the dose of rFVIIa is not well described in the literature. MATERIALS AND METHODS:All adult patients that received off-label rFVIIa from 2005-2012 were inclu...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.02.026

    authors: Bucklin MH,Acquisto NM,Nelson C

    更新日期:2014-05-01 00:00:00

  • Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture.

    abstract::Lysophosphatidic acid (LPA) is a lipid mediator generated by activated platelets and having various effects on numerous cell types. We investigated some effects of 1-oleyl LPA on vascular smooth muscle cells cultured from adult human normal arteries. At micromolar concentrations, LPA induced a mitogenic effect ([3H]-t...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(99)00004-3

    authors: Gennero I,Xuereb JM,Simon MF,Girolami JP,Bascands JL,Chap H,Boneu B,Sié P

    更新日期:1999-06-01 00:00:00

  • Impaired fibrinolysis and protein C increase after cadaver kidney transplantation.

    abstract::Severe rejection crises occurred in 13 out of 20 cadaver kidney recipients; removal of the graft was inevitable in 10 cases. The plasminogen levels were found to be lower (76.5 +/- 2.9%) in the 13 patients with impaired graft acceptance (group B) than in the 7 patients experiencing only moderate rejection (group A, 93...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90257-4

    authors: Seitz R,Michalik R,Karges HE,Lange H,Egbring R

    更新日期:1986-05-01 00:00:00

  • Effect of intensive glycemic control on platelet reactivity in patients with long-standing uncontrolled diabetes.

    abstract:BACKGROUND:It has been previously shown that platelets of patients with diabetes are more reactive and less responsive to anti-platelet drugs compared with platelets from subjects without diabetes. Studies examining the effect of glycemic control on platelet reactivity have yielded conflicting data. Thus, in this study...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.05.010

    authors: Singer J,Weissler Snir A,Leshem-Lev D,Rigler M,Kornowski R,Lev EI

    更新日期:2014-07-01 00:00:00

  • Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model.

    abstract:BACKGROUND:Cardiovascular disease remains the leading cause of morbidity and premature mortality in most industrialized countries as well as in developing nations. A pro-oxidative state appears to promote and/or exacerbate vascular disease complications. Furthermore, a state of low-grade chronic inflammation can promot...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2010.07.003

    authors: Khan SK,Malinski T,Mason RP,Kubant R,Jacob RF,Fujioka K,Denstaedt SJ,King TJ,Jackson HL,Hieber AD,Lockwood SF,Goodin TH,Pashkow FJ,Bodary PF

    更新日期:2010-10-01 00:00:00

  • Thrombin treated plasma employed as a standard for determination of soluble fibrin.

    abstract::The Coa-set Fibrin Monomer test (CFM-test) is a quantitative method for determination of soluble fibrin in plasma. The fibrin standard of the CFM-test is produced by bathroxobin conversion of purified fibrinogen to fibrin. Plasma treated with minute amounts of thrombin may be considered as a more physiological way of ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(93)90139-f

    authors: Halvorsen S,Skjønsberg OH,Godal HC

    更新日期:1993-11-15 00:00:00

  • 'Pergularain e I'--a plant cysteine protease with thrombin-like activity from Pergularia extensa latex.

    abstract::Pergularain e I, a cysteine protease with thrombin-like activity, was purified by ion exchange chromatography from the latex of Pergularia extensa. Its homogeneity was characterized by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), native PAGE and reverse-phase high-performance liquid chromatogr...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.10.002

    authors: Shivaprasad HV,Rajaiah R,Frey BM,Frey FJ,Vishwanath BS

    更新日期:2010-03-01 00:00:00

  • High molecular weight kininogen, the extracellular inhibitor of thiol proteases, is deficient in hamsters with muscular dystrophy.

    abstract::High molecular weight kininogen has been shown to be the principal plasma inhibitor of cellular thiol proteases including cathepsins B, H and L and calpains 1 and 2. Since these same enzymes have been reported to be elevated in animals with muscular dystrophy, we studied plasmas from hamsters with muscular dystrophy a...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(89)90041-8

    authors: Colman RW,Bradford HN,Warner AH

    更新日期:1989-04-15 00:00:00

  • Mechanisms of hormonal therapy related thrombosis.

    abstract::There is now compelling evidence that use of oral contraceptives and postmenopausal hormonal therapies containing various estrogens is associated with a weak, but clinically relevant risk of both arterial and venous thrombosis. The increased risk is related to type and dose of both estrogen and combined progestagen an...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/S0049-3848(13)70009-4

    authors: Sandset PM

    更新日期:2013-01-01 00:00:00

  • Prevalence and risk factors of atherothrombotic events among 1054 hemophilia patients: a population-based analysis.

    abstract:INTRODUCTION:Reports on the prevalence and risk factors of atherothrombotic events (AEs) are conflicting in persons with hemophilia (PWH). METHODS:This study evaluated the prevalence and risk factors of AEs among 1054 male hemophilia patients, using data collected from Taiwan's National Health Insurance Research Datab...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.12.027

    authors: Wang JD,Chan WC,Fu YC,Tong KM,Chang ST,Hwang WL,Lin CH,Tsan YT

    更新日期:2015-03-01 00:00:00

  • The effect of delayed analysis or freeze-thawing on the measurement of natural anticoagulants, resistance to activated protein C and markers of activation of the haemostatic system.

    abstract::We provide a centralised thrombophilia screening service with sample transfer by courier or first class mail, a practice common to many centres. Sample quality is of prime importance, thus we have assessed the effect of delayed sample handling upon the haemostatic variables within our thrombophilia profile. This compr...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(97)00187-4

    authors: Luddington R,Peters J,Baker P,Baglin T

    更新日期:1997-09-15 00:00:00

  • The acute prothrombotic effect of aldosterone in rats is partially mediated via angiotensin II receptor type 1.

    abstract:INTRODUCTION:We showed previously that the prothrombotic effect of one hour aldosterone (ALDO) infusion in rats was only partially mediated by the mineralocorticoid receptor (MR). Bearing in mind that ALDO potentiates the effects of angiotensin II (Ang II), in the present study we investigated the role of Ang II recept...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2015.12.008

    authors: Gromotowicz-Poplawska A,Stankiewicz A,Kramkowski K,Gradzka A,Wojewodzka-Zelezniakowicz M,Dzieciol J,Szemraj J,Chabielska E

    更新日期:2016-02-01 00:00:00

  • Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.

    abstract::Adenosine is an endogenous antiaggregating substance that influences the platelet responses through specific A-type receptors that activate adenylate cyclase increasing the levels of 3',5'-cyclic adenosine monophosphate (cAMP). In this study, we investigated whether adenosine can also influence the levels of 3',5'-cyc...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00412-1

    authors: Anfossi G,Russo I,Massucco P,Mattiello L,Cavalot F,Balbo A,Trovati M

    更新日期:2002-01-01 00:00:00

  • Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head.

    abstract:INTRODUCTION:To test the hypothesis that the platelet microparticle (PMP) and endothelial microparticle (EMP) may contribute to the hypercoagulability associated with microvascular thrombosis in patients with nontraumatc osteonecrosis of the femoral head (ONFH). MATERIALS AND METHODS:The study comprised 46 patients wh...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2008.04.001

    authors: Kang P,Shen B,Yang J,Pei F

    更新日期:2008-01-01 00:00:00

  • The inactivation of one- and two-chain forms of tissue plasminogen activator by a series of peptidyl chloromethyl ketones.

    abstract::The inhibition of one- and two-chain forms of tissue-type plasminogen activator by a series of peptide derivatives of arginine chloromethyl ketone was studied. Both forms of the enzyme were inhibited by such reagents at varying rates, dependent on the peptide sequence of the inhibitor. The order of relative effectiven...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90133-7

    authors: Green GD

    更新日期:1986-10-15 00:00:00

  • Comparison of antithrombin activity of the polysulphate chitosan derivatives in in vivo and in vitro system.

    abstract::In order to choose the proper method for evaluating the antithrombin activity in samples of chitosan polysulphate (CP) with different polymerization degrees and sulphation degrees, we estimated the ability of direct anticoagulants to depress the coagulability of recalcified sheep blood using the third international he...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00266-3

    authors: Drozd NN,Sher AI,Makarov VA,Galbraikh LS,Vikhoreva GA,Gorbachiova IN

    更新日期:2001-06-01 00:00:00

  • Known knowns and known unknowns: risks associated with combination antithrombotic therapy.

    abstract:BACKGROUND:Use of antiplatelet therapy in combination with oral anticoagulants remains controversial. The purpose of this article is to review current consensus recommendations for antithrombotic therapy, to evaluate risks for bleeding among patients taking combination antithrombotic therapy, and lastly to review singl...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2008.08.011

    authors: Johnson S

    更新日期:2008-01-01 00:00:00

  • To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

    abstract::Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long term complication of acute pulmonary embolism (PE). Untreated, CTEPH is associated with a very poor prognosis and high risk of mortality, although curation can be achieved by surgical removal of the obstructive endothelialised thromboemboli ...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2016.12.026

    authors: Ende-Verhaar YM,Huisman MV,Klok FA

    更新日期:2017-03-01 00:00:00

  • Construction and its expression of a new retroviral vector containing a human blood coagulation factor IX cDNA.

    abstract::We constructed a new factor IX expression vector containing a full length factor IX cDNA. The Moloney Murine Leukemia Virus (MoMLV)-based retroviral vector pLRNL was cloned with the entire coding region of human factor IX down stream of the promoter of Rous sarcoma virus, giving rise to the construct pL9RNL. The GP+E ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(93)90038-p

    authors: Matsushita T,Emi N,Takahashi I,Takamatsu J,Saito H

    更新日期:1993-02-15 00:00:00

  • Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges.

    abstract::A synthetic pentasaccharide, representing the critical sequence required in heparin for binding to antithrombin III (AT III), produces strong anti-factor Xa activity in vitro in the presence of AT III and is devoid of any activity directed towards thrombin. This pentasaccharide provides a unique tool to study the ques...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90280-5

    authors: Walenga JM,Petitou M,Lormeau JC,Samama M,Fareed J,Choay J

    更新日期:1987-04-15 00:00:00

  • Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study.

    abstract:INTRODUCTION:An individualised thromboprophylaxis was implemented in critically ill patients suffering from coronavirus disease 2019 (COVID-19) pneumonia to reduce mortality and improve clinical outcome. The aim of this study was to evaluate the effect of this intervention on clinical outcome. METHODS:In this mono-cen...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.07.038

    authors: Stessel B,Vanvuchelen C,Bruckers L,Geebelen L,Callebaut I,Vandenbrande J,Pellens B,Van Tornout M,Ory JP,van Halem K,Messiaen P,Herbots L,Ramaekers D,Dubois J

    更新日期:2020-10-01 00:00:00

  • Interleukin 1 enhances arterial thrombogenicity in vitro.

    abstract::An in vitro model of platelet adhesion, the annular perfusion chamber, was utilized to test the effects of Interleukin 1 on vascular thrombogenicity for platelets. De-endothelialized, everted human umbilical arteries were placed in cell culture media with or without Interleukin 1. The arteries were later perfused with...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(89)90235-1

    authors: Schorer AE,White JG

    更新日期:1989-11-15 00:00:00

  • Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension.

    abstract:INTRODUCTION:Pathogenesis of idiopathic pulmonary arterial hypertension (iPAH) includes endothelial dysfunction and in situ thrombosis. A hypercoagulable state has also been postulated but never demonstrated. Our objective was to determine whether patients with iPAH had a hypercoagulable state using calibrated automate...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2010.08.020

    authors: Tournier A,Wahl D,Chaouat A,Max JP,Regnault V,Lecompte T,Chabot F

    更新日期:2010-12-01 00:00:00

  • Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months.

    abstract::We report an inbred family with two cases of homozygous protein C deficiency and review 11 other such cases. Both patients presented in the second half of their first year of life with recurrent rapidly disappearing ecchymotic skin lesions, disseminated intravascular coagulation, and venous thrombosis. Successful trea...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/0049-3848(89)90202-8

    authors: Tuddenham EG,Takase T,Thomas AE,Awidi AS,Madanat FF,Abu Hajir MM,Kernoff PB,Hoffbrand AV

    更新日期:1989-03-01 00:00:00